23and me stock.

Get the detailed quarterly/annual income statement for 23andMe Holding Co. (ME). Find out the revenue, expenses and profit or loss over the last fiscal year.

23and me stock. Things To Know About 23and me stock.

Stock price history for 23andMe (ME) Highest end of day price: $17.65 USD on 2021-02-04. Lowest end of day price: $0.71 USD on 2023-11-09. Stock price history of 23andMe from 2020 to 2023. What is the market capitalization of a company?The Zacks database contains over 10,000 stocks. All of those stocks are classified into three groups: Sector, M Industry and X (Expanded) Industry. There are 17 Sectors, 60 different M Industries ...ME. +6.60%. Shares of 23andMe Holding Co. ME rallied more than 12% in the extended session Wednesday after the genetics company raised guidance for 2023. 23andMe lost $92 million, or 20 cents a ...Nov 25, 2023 · View 23andMe Holding Co ME investment & stock information. Get the latest 23andMe Holding Co ME detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

2 Wall Street research analysts have issued 1-year price objectives for 23andMe's shares. Their ME share price targets range from $1.75 to $7.00. On average, they anticipate the company's stock price to reach $4.38 in the next year. This suggests a possible upside of 381.4% from the stock's current price.This decision also allows 23andMe to strategically invest capital and resources into advancing our diverse portfolio of therapeutic programs.” 23andMe’s Therapeutics team was established in 2015 with the goal to improve the way drug discovery is currently conducted by starting with human genetic information.

The Wall Street analyst predicted that 23andme Holding Co's share price could reach $1.75 by Aug 10, 2024. The average 23andme Holding Co stock price prediction ...

23andMe Holding Co. (NASDAQ:ME) Q2 2024 Earnings Call Transcript. 23andMe Holding Co. (NASDAQ:ME) Q2 2024 Earnings Call Transcript November 8, 2023 23andMe …A high-level overview of 23andMe Holding Co. (ME) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.I would rate 23andMe a buy rating. Although the stock price is a bit shaky and volatile, when thinking about the long term, the company has high potential to be big in the genomics testing space ...Aug 8, 2022 · Shares of genetic data healthcare company 23andMe ( ME -0.86%) jumped higher on Monday morning, as did many other beaten-down stocks. By noon ET, 23andMe stock was up 16% and trading volume was ... Through this process, the company raised $560 million and began trading at $10 a share. Immediately after the SPAC announced the future acquisition of 23andMe, the stock immediately popped to ...

Since its IPO on the Shenzhen stock exchange, its share price has gone up every day by the exact same amount. Baofeng Technologies is China’s best performing stock this year. Since its IPO on the Shenzhen stock exchange, its share price has...

Q3 2024 EPS Estimate Trends. Current. -$0.15. 1 Month Ago. -$0.15. 3 Months Ago. -$0.18. 23andMe Holding Co. analyst estimates, including ME earnings per share estimates and analyst recommendations.If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...The transaction will value the outstanding shares of capital stock of 23andMe at an aggregate enterprise value of approximately $3.5 billion. 23andMe CEO and Co-Founder Anne Wojcicki and Virgin Group’s Richard Branson are each investing $25 million into the $250 million PIPE and are joined by leading institutional investors including …See the latest 23andMe Holding Co Class A stock price (ME:XNAS), related news, valuation, dividends and more to help you make your investing decisions.NEW YORK, NY / ACCESSWIRE / December 4, 2023 / 23andMe, a popular personal genomics and DNA analysis company run by 23andMe Holding Co. …

Q3 2024 EPS Estimate Trends. Current. -$0.15. 1 Month Ago. -$0.15. 3 Months Ago. -$0.18. 23andMe Holding Co. analyst estimates, including ME earnings per share estimates and analyst recommendations.Nov 21, 2022 · 23andMe Holding Co. ( NASDAQ: ME) is a genomics research company that aims to make genetic testing commonplace and mainstream. The global genomics industry was valued at $27.81 billion in 2021 and ... Things got even worse today, when investors responded to a downgrade of 23andMe stock by a Citigroup analyst -- by selling off the stock by 10.1% (as of 11:30 a.m. EST). Image source: Getty Images ...Things got even worse today, when investors responded to a downgrade of 23andMe stock by a Citigroup analyst -- by selling off the stock by 10.1% (as of 11:30 a.m. EST). Image source: Getty Images ...NEW YORK, NY / ACCESSWIRE / December 4, 2023 / 23andMe, a popular personal genomics and DNA analysis company run by 23andMe Holding Co. ("23 and Me") (NASDAQ:ME), recently suffered a massive data leak. The attack targeted the personal information of 23andMe users -more than 4 million people- compromising …

Find the latest 23andMe Holding Co. (ME) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.

4 de fev. de 2021 ... SirRichardBranson #23andMe #SPAC Virgin Group Founder Sir Richard Branson and 23andMe CEO & Co-Founder Annew Wojcicki join Yahoo Finance to ...23andMe, the genetics testing startup that’s been trading fun facts about people’s heritage for saliva-covered swabs since 2006, will soon be a $3.5 billion publicly traded company, thanks to an SPAC merger with British billionaire Richard Branson’s Virgin Group. Branson says he sees 23andMe as a company with “enormous growth potential.”.23andMe is known for its ancestry DNA genetic testing service, but the company faces disruption from whole genome sequencing. Read why I rate ME stock a sell.há 2 dias ... Is 23andMe Holding Stock Undervalued? The current 23andMe Holding [ME] share price is $0.89. The Score for ME is 29, which is 42% below its ...Aug 11, 2022 · By Bret Kenwell, InvestorPlace Contributor Aug 11, 2022, 3:12 pm EST. 23andMe ( ME) stock has more than doubled so far this month, with shares up 127% at today’s high from the July 29 low ... 17 de ago. de 2021 ... 23andMe has 'a core competitive advantage that is not easily replicated,' Credit Suisse says.Nov 30, 2023 · A. The latest price target for 23andMe Holding ( NASDAQ: ME) was reported by Citigroup on Thursday, August 10, 2023. The analyst firm set a price target for 1.75 expecting ME to rise to within 12 ...

Jun 18, 2021 · The SPAC merger gave 23andMe an equity value of $4.45 billion, and its stock surge boosted its equity value to around $5.92 billion. After adjusting for its $984 million in pro forma net cash, we ...

Jan 31, 2022 · Step 4: Execute your trade. To execute a market order, follow these steps: Select action type (buy or sell). Enter the shares you want to acquire (or sell). Hit the buy (or sell) button. Use the ...

See the company profile for 23andMe Holding Co. (ME) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their ...Shares of 23andMe ( ME 3.72%) dropped 29.1% in November, according to data from S&P Global Market Intelligence. The DNA testing and therapeutics company reported a disappointing quarterly report ...Stock Price Forecast. The 3 analysts offering 12-month price forecasts for 23andMe Holding Co. have a median target of 3.00, with a high estimate of 6.00 and a low estimate of 0.90. The median ... 23andMe Holding Co. is the leading direct-to-consumer genetic testing company entering drug development with data on 11.3M Genotyped Customers and +$696M in SPAC funding.This price target is based on 2 analysts offering 12 month price targets for 23andMe in the last 3 months. The average price target is $4.38, with a high forecast of $7.00 and a low forecast of $1.75. The average price target represents a 370.58% upside from the last price of …Shares of 23andMe Holding ( ME 3.64%) stock slipped in Friday morning trading after the genetic data miner announced that it will spend $400 million to acquire on-demand online medical care and ...23andMe says only 0.1% of user accounts affected in data breach. 23andMe Holding ( NASDAQ: ME) traded higher on Monday after announcing in a regulatory filing that hackers accessed only 0.1% of ...23andMe Stock Earnings. The value each ME share was expected to gain vs. the value that each ME share actually gained. 23andMe ( ME) reported Q3 2023 earnings per share (EPS) of -$0.16, missing estimates of -$0.14 by 12.80%. In the same quarter last year, 23andMe 's earnings per share (EPS) was -$0.15. 23andMe is expected to release next ...The combined company is owned by 23andMe Holding Co. Richard Branson and CEO Anne Wojcicki are major stakeholders. Other investors include Altimeter Capital, Fidelity, and Foresite Capital. Since the company was founded in 2006, it has been involved in multiple funding rounds. There were at least 60 investors in 2020 before the merger ...23andMe to Report FY2024 Second Quarter Financial Results. SOUTH SAN FRANCISCO, Calif., Oct. 25, 2023 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company with a mission to help people access, understand, and benefit from the human genome, announced …Scores. ME has an Altman Z-Score of -2.3 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy. Altman Z-Score. -2.3. Piotroski F-Score. 3. Detailed statistics for 23andMe Holding Co. (ME) stock, including valuation metrics, financial numbers, share information and more.

23andMe Holding Co. (NASDAQ:ME) Q2 2024 Earnings Call Transcript. 23andMe Holding Co. (NASDAQ:ME) Q2 2024 Earnings Call Transcript November 8, 2023 23andMe …23andMe will host a conference call at 4:30 p.m. Eastern Time on Thursday, May 26th, 2022 to discuss the financial results for the full year and Q4 FY2022 and report on business progress. ... non-cash stock-based compensation expense, acquisition-related costs, litigation settlements not related to normal and continued business activities, and ...To be assigned a Value Score, stocks must have a valid (non-null) ratio and corresponding ranking for at least two of the six valuation ratios. Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are a good value and so on. 23andMe Holding Co. has a Value Score of 51, which is Average.Instagram:https://instagram. best uk stock brokersusaa pet insurance ratestop day trading softwarewhich broker is best for forex trading 23andMe is a genomics and biotechnology company that provides health reports to consumers by analyzing their DNA. The company's services include the analysis of one's genome for ancestry breakdown ...The average price point forecasted by analysts for 23andMe Holding Co (ME) is $3.30, which is $2.76 above the current market price. The public float for ME is 269.01M, and currently, short sellers hold a 10.00% ratio of that float. The average trading volume of ME on November 17, 2023 was 3.39M shares. ME) stock’s […] best investment classessandp 500 value etf 23andMe Holding Co. is a publicly held personal genomics and biotechnology company based in South San Francisco, ... The combined company was renamed to 23andMe … gas etf stocks Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.Shares of genetic data healthcare company 23andMe ( ME -0.86%) jumped higher on Monday morning, as did many other beaten-down stocks. By noon ET, 23andMe stock was up 16% and trading volume was ...Stock control is important because it prevents retailers from running out of products, according to the Houston Chronicle. Stock control also helps retailers keep track of goods that may have been lost or stolen.